First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-08-30 23:00:22Open Document File Size: 119,20 KBShare Result on FacebookCompanyCangene Corporation / FFF Enterprises / /CountryUnited States / / /IndustryTermexpanded access protocol / treatment site / monitor for sign and symptoms / /MedicalConditionvaricella disease / disease / acute illness / chickenpox / herpes zoster / mild atypical varicella / typical varicella case / diseases / varicella zoster immune globulin / varicella virus / prior infection / past disease / illness / severe disease / varicella / typical disease / /MedicalTreatmentvaccination / /OrganizationAdvisory Committee on Immunization Practices / Administration of VariZIG™ / Massachusetts Department of Public Health Division of Epidemiology and Immunization VariZIG™ Investigational New Drug Available for Postexposure Prophylaxis / FDA / If administration / Public Health Division of Epidemiology and Immunization VariZIG™ Investigational New Drug Available for Postexposure Prophylaxis of Varicella / / /Positioninvestigator / physician / /Productacyclovir / /ProvinceOrStateIndiana / /Technologyexpanded access protocol / /URLhttp /SocialTag |